Terminated NA INTERVENTIONAL 2-arm NCT03092154

Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis

Sponsor: University of Sao Paulo

Interventions Lipid-lowering agents (Artovastatin)

Updated 9 times since 2017 Last updated: May 31, 2022 Started: Jan 31, 2017 Primary completion: May 31, 2022 Completion: May 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from University of Sao Paulo

See all terminations from University of Sao Paulo

This NA trial investigates Treatment Side Effects and is currently terminated or withdrawn. University of Sao Paulo leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jul 2022 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jan 2021 — Jul 2022 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Apr 2020 — Jan 2021 [monthly]

Recruiting NA
Dec 2018 — Apr 2020 [monthly]

Recruiting NA
Jun 2018 — Dec 2018 [monthly]

Recruiting NA
Apr 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil